Bromley, Susan D.,Parlati, Francesco,Gross, Matthew I.,Orford, Keith
申请号：
AU2018231058
公开号：
AU2018231058A1
申请日:
2018.03.09
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The invention relates to methods of treating cancer or myeloproliferative diseases with a combination of a glutaminase inhibitor and a second anticancer agent such as osimertinib, pazopanib, navitoclax, palbociclib, or olaparib. The invention further relates to methods of treating cancer or myeloproliferative diseases with a combination of a glutaminase inhibitor and conventional radiotherapy or stereotactic body radiotherapy.
